SGRY has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
SGRY has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today (2024-04-27), Surgery Partners's current share price is $24.55. Surgery Partners's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was $33.26. Surgery Partners's Cyclically Adjusted PS Ratio for today is 0.74.
The historical rank and industry rank for Surgery Partners's Cyclically Adjusted PS Ratio or its related term are showing as below:
During the past years, Surgery Partners's highest Cyclically Adjusted PS Ratio was 1.03. The lowest was 0.67. And the median was 0.94.
The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.
Surgery Partners's adjusted revenue per share data for the three months ended in Dec. 2023 was $5.847. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $33.26 for the trailing ten years ended in Dec. 2023.
The historical data trend for Surgery Partners's Cyclically Adjusted PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Surgery Partners Quarterly Data | ||||||||||||||||||||
Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | |
Cyclically Adjusted PS Ratio | Get a 7-Day Free Trial | - | - | - | 0.87 | 0.96 |
For the Medical Care Facilities subindustry, Surgery Partners's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Providers & Services industry and Healthcare sector, Surgery Partners's Cyclically Adjusted PS Ratio distribution charts can be found below:
* The bar in red indicates where Surgery Partners's Cyclically Adjusted PS Ratio falls into.
Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.
Surgery Partners's Cyclically Adjusted PS Ratio for today is calculated as
Cyclically Adjusted PS Ratio | = | Share Price | / | Cyclically Adjusted Revenue per Share |
= | 24.55 | / | 33.26 | |
= | 0.74 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Surgery Partners's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 is calculated as:
For example, Surgery Partners's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:
Adj_RevenuePerShare | = | Revenue per Share | / | CPI of Dec. 2023 (Change) | * | Current CPI (Dec. 2023) |
= | 5.847 | / | 129.4194 | * | 129.4194 | |
= | 5.847 |
Current CPI (Dec. 2023) = 129.4194.
Surgery Partners Quarterly Data
Revenue per Share | CPI | Adj_RevenuePerShare | |
201312 | 0.000 | 98.326 | 0.000 |
201406 | 0.000 | 100.560 | 0.000 |
201409 | 1.584 | 100.428 | 2.041 |
201412 | 3.731 | 99.070 | 4.874 |
201503 | 4.654 | 99.621 | 6.046 |
201506 | 4.835 | 100.684 | 6.215 |
201509 | 4.975 | 100.392 | 6.414 |
201512 | 5.468 | 99.792 | 7.091 |
201603 | 5.562 | 100.470 | 7.165 |
201606 | 6.019 | 101.688 | 7.660 |
201609 | 5.887 | 101.861 | 7.480 |
201612 | 6.282 | 101.863 | 7.981 |
201703 | 5.960 | 102.862 | 7.499 |
201706 | 5.989 | 103.349 | 7.500 |
201709 | 0.000 | 104.136 | 0.000 |
201712 | 0.000 | 104.011 | 0.000 |
201803 | 8.568 | 105.290 | 10.532 |
201806 | 9.093 | 106.317 | 11.069 |
201809 | 9.001 | 106.507 | 10.937 |
201812 | 10.222 | 105.998 | 12.481 |
201903 | 8.675 | 107.251 | 10.468 |
201906 | 9.223 | 108.070 | 11.045 |
201909 | 9.356 | 108.329 | 11.177 |
201912 | 10.703 | 108.420 | 12.776 |
202003 | 9.098 | 108.902 | 10.812 |
202006 | 7.672 | 108.767 | 9.129 |
202009 | 10.149 | 109.815 | 11.961 |
202012 | 11.214 | 109.897 | 13.206 |
202103 | 9.355 | 111.754 | 10.834 |
202106 | 7.844 | 114.631 | 8.856 |
202109 | 6.927 | 115.734 | 7.746 |
202112 | 7.208 | 117.630 | 7.930 |
202203 | 6.604 | 121.301 | 7.046 |
202206 | 6.922 | 125.017 | 7.166 |
202209 | 6.980 | 125.227 | 7.214 |
202212 | 6.933 | 125.222 | 7.165 |
202303 | 5.321 | 127.348 | 5.408 |
202306 | 5.241 | 128.729 | 5.269 |
202309 | 5.361 | 129.860 | 5.343 |
202312 | 5.847 | 129.419 | 5.847 |
Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.
Thank you for viewing the detailed overview of Surgery Partners's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Bain Capital Investors Llc | director, 10 percent owner | 200 CLARENDON STREET, BOSTON MA 02116 |
Wayne S Deveydt | director, officer: Chief Executive Officer | 120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204 |
T. Devin O'reilly | director, 10 percent owner | C/O BAIN CAPITAL PRIVATE EQUITY, LP, 200 CLARENDON STREET, BOSTON MA 02149 |
Blair E Hendrix | director, 10 percent owner | |
Andrew T. Kaplan | director | C/O BAIN CAPITAL PRIVATE EQUITY, LP, 200 CLARENDON STREET, BOSTON MA 02116 |
Jason Eric Evans | officer: EVP & Chief Operating Officer | 310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027 |
Harrison R. Bane | officer: American Group President | 310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027 |
David T Doherty | officer: Chief Financial Officer | 310 SEVEN SPRINGS WAY, BRENTWOOD TN 37027 |
Bradley R. Owens | officer: National Group President | 310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027 |
Danielle Burkhalter | officer: Chief Human Resources Officer | 310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027 |
Anthony Taparo | officer: President, Atlantic Group | 310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027 |
Jennifer Baldock | officer: Sr. VP, Gen Couns. & Sec. | 310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027 |
Marissa Brittenham | officer: Chief Strategy Officer | 310 SEVEN SPRINGS WAY, BRENTWOOD TN 37027 |
Bain Capital Fund Xi, L.p. | director, 10 percent owner | JOHN HANCOCK TOWER, 200 CLARENDON STREET, BOSTON MA 02116 |
Bain Capital Partners Xi, L.p. | director, 10 percent owner | 200 CLARENDON STREET, BOSTON MA 02116 |
From GuruFocus
By GuruFocusNews GuruFocusNews • 04-07-2022
By GuruFocusNews GuruFocusNews • 02-03-2022
By GuruFocus Research • 09-06-2023
By GuruFocus Research • 11-07-2023
By GuruFocusNews GuruFocusNews • 05-03-2022
By sperokesalga sperokesalga • 04-19-2023
By Stock market mentor Stock market mentor • 01-03-2023
By GuruFocus Research • 10-11-2023
By GuruFocusNews GuruFocusNews • 06-12-2022
By PurpleRose PurpleRose • 07-12-2022